SM

Sabby Management

North America, New Jersey, United States, Saddle River

Description

Based in New Jersey, Sabby Management is a hedge fund that offers a range of funding and investment advisory services.

Investor Profile

Sabby Management has made 10 investments, with 0 in the past 12 months and 20% as lead.

Stage Focus

  • Post Ipo Equity (50%)
  • Series Unknown (20%)
  • Series E (10%)
  • Series B (10%)
  • Series C (10%)

Country Focus

  • United States (90%)
  • Israel (10%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Medical Device
  • Hospital
  • Precision Medicine
  • Biopharma
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sabby Management frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Broadfin Capital
North America, New York, United States, New York
Co-Investments: 2
Senvest Capital
North America, Quebec, Canada, Montreal
Co-Investments: 1
Migdal Insurance and Financial Holdings
Asia, HaMerkaz, Israel, Petah Tikwah
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Deerfield
North America, New York, United States, New York
Co-Investments: 2
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 2
Jennison Associates
North America, New York, United States, New York
Co-Investments: 2
Armistice Capital
North America, New York, United States, New York
Co-Investments: 1

Which angels does Sabby Management often collaborate with?

Shared Deals: 1

What are some of recent deals done by Sabby Management?

Epic Sciences

La Jolla, California, United States

Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.

BiotechnologyHealth CareHealth DiagnosticsHospitalPrecision Medicine
Series ESep 12, 2018
Amount Raised: $52,000,000
Strata Skin Sciences

Horsham, Pennsylvania, United States

Strata Skin Sciences is a medical technology company that specializes in dermatology and plastic surgery.

Health CareMedicalMedical Device
Post Ipo EquityApr 2, 2018
Amount Raised: $17,000,000
OpGen

Rockville, Maryland, United States

OpGen is a precision medicine company utilizing molecular diagnostics and bioinformatics to help combat infectious disease.

BiotechnologyGeneticsHealth CarePrecision Medicine
Post Ipo EquityMay 20, 2016
Amount Raised: $10,400,000
Xeris Biopharma

Chicago, Illinois, United States

Xeris Biopharma is a pharmaceutical company that develops therapies for patients in endocrinology, neurology, and gastroenterology.

BiotechnologyDiabetesHealth CarePharmaceuticalTherapeutics
Series CJan 7, 2016
Amount Raised: $41,000,000
Celladon

La Jolla, California, United States

Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure.

BiotechnologyHealth CareHospitalTherapeutics
Post Ipo EquityNov 18, 2015
Amount Raised: $39,500,000
Outlook Therapeutics

Iselin, New Jersey, United States

Outlook Therapeutics is a biopharmaceutical company that develops ophthalmic formulations.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Series UnknownSep 29, 2015
Cogent Biosciences

Waltham, Massachusetts, United States

Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.

BiotechnologyHealth CareMedicalTherapeutics
Series BJun 11, 2015
Amount Raised: $65,000,000
Tonix Pharmaceuticals

New York, New York, United States

Tonix Pharmaceuticals develops pharmaceutical products for central nervous system disorders.

BiopharmaBiotechnologyMedicalPharmaceutical
Post Ipo EquityFeb 3, 2015
Amount Raised: $28,700,000
Nivalis Therapeutics

Boulder, Colorado, United States

Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.

BiotechnologyHealth CareTherapeutics
Series UnknownNov 19, 2014
Amount Raised: $30,000,000
Medigus

Omez, HaMerkaz, Israel

Medigus is a medical device company focused on developing innovative endoscopic procedures and devices.

BiotechnologyHealth CareManufacturingMedical Device
Post Ipo EquityJun 29, 2014
Amount Raised: $11,100,000